China is targeting the globe’s most expensive drugs with a bold mission: to dramatically cut costs and make life-saving treatments accessible to more patients. This ambitious move is shaking up the global pharmaceutical scene, transforming pricing strategies and sparking fresh waves of innovation throughout the industry